摘要
转基因植物作为生物反应器生产重要的药用蛋白,如抗体、血液替代品和疫苗,为健康保健和科学研究提供充足的生物药物,满足人们日益增长的需要。本文综述了这一领域的研究进展以及商业化前景。
Transgenic plant as bioreactor has been used to produce recombinant proteins for medicinal purposes,including mammalian antibodies,blood substitutes and vaccines.As the demand for biopharmaceuticals is expected to increase,transgenic plants have the potential to provide virtually unlimited quantities of proteins for use as tools in both human health care and the bioscience.This paper reviews the recent developments in this field and the prospect of commercial applications.
出处
《遗传》
CAS
CSCD
北大核心
2003年第1期107-112,共6页
Hereditas（Beijing)
基金
国家植物转基因中试及产业化基地资助(J99-B-001)
